Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Rubenstein

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
The Journal of Prosthetic Dentistry|December 31, 2024
Assessment of the internal connection of an angled screw channel systemSeoyoun Hahn, Van Ramos, Jonathan An, et al.
Epilepsia|February 28, 2006
A modified Atkins diet is effective for the treatment of intractable pediatric epilepsyEric H Kossoff, Jane R McGrogan, Renee M Bluml, et al.
Physical Therapy|September 1, 1978
Primitive reflex profile. A pilot studyA J Capute, P J Accardo, E P Vining, et al.
Pharmacoepidemiology and Drug Safety|January 23, 2002
A claims data approach to defining an episode of careK A Schulman, K R Yabroff, J Kong, et al.
Epilepsia|April 9, 2005
Can you predict an immediate, complete, and sustained response to the ketogenic diet?Khoi D Than, Eric H Kossoff, James E Rubenstein, et al.
Health Services Research|June 5, 1999
A claims data approach to defining an episode of careK A Schulman, K R Yabroff, J Kong, et al.
Journal of Child Neurology|March 29, 2005
Experience in the use of the ketogenic diet as early therapyJames E Rubenstein, Eric H Kossoff, Paula L Pyzik, et al.
Epilepsia|February 28, 2006
The outcome of children with intractable seizures: a 3- to 6-year follow-up of 67 children who remained on the ketogenic diet less than one yearElisabeth B Marsh, John M Freeman, Eric H Kossoff, et al.
Molecular Cancer Therapeutics|July 21, 2010
The novel Hsp90 inhibitor NXD30001 induces tumor regression in a genetically engineered mouse model of glioblastoma multiformeHaihao Zhu, Steve Woolfenden, Roderick T Bronson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up studyW S Velasquez, P McLaughlin, S Tucker, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
The Journal of Prosthetic Dentistry|December 31, 2024
Assessment of the internal connection of an angled screw channel systemSeoyoun Hahn, Van Ramos, Jonathan An, et al.
Epilepsia|February 28, 2006
A modified Atkins diet is effective for the treatment of intractable pediatric epilepsyEric H Kossoff, Jane R McGrogan, Renee M Bluml, et al.
Physical Therapy|September 1, 1978
Primitive reflex profile. A pilot studyA J Capute, P J Accardo, E P Vining, et al.
Pharmacoepidemiology and Drug Safety|January 23, 2002
A claims data approach to defining an episode of careK A Schulman, K R Yabroff, J Kong, et al.
Epilepsia|April 9, 2005
Can you predict an immediate, complete, and sustained response to the ketogenic diet?Khoi D Than, Eric H Kossoff, James E Rubenstein, et al.
Health Services Research|June 5, 1999
A claims data approach to defining an episode of careK A Schulman, K R Yabroff, J Kong, et al.
Journal of Child Neurology|March 29, 2005
Experience in the use of the ketogenic diet as early therapyJames E Rubenstein, Eric H Kossoff, Paula L Pyzik, et al.
Epilepsia|February 28, 2006
The outcome of children with intractable seizures: a 3- to 6-year follow-up of 67 children who remained on the ketogenic diet less than one yearElisabeth B Marsh, John M Freeman, Eric H Kossoff, et al.
Molecular Cancer Therapeutics|July 21, 2010
The novel Hsp90 inhibitor NXD30001 induces tumor regression in a genetically engineered mouse model of glioblastoma multiformeHaihao Zhu, Steve Woolfenden, Roderick T Bronson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up studyW S Velasquez, P McLaughlin, S Tucker, et al.
Pageof 14